Arrayit Corporation
524 East Weddell Drive
Sunnyvale, CA 94089
USA
Phone 408-744-1331
FAX 408-744-1711
Email arrayit@arrayit.com
Web www.arrayit.com
Twitter www.twitter.com/arrayit
 

Corporate Newsletter
Click here to sign up for the Arrayit newsletter.

Recent News
2/2/12 Arrayit's CEO, Rene Schena, Chosen to Promote Economic Growth Center to Big Pharma and Biotech Businesses.
12/14/11 Arrayit Corporation to Spin-Off Arrayit Diagnostics, Inc. to Shareholders.
8/3/11 Arrayit Corporation Reports 47% Revenue Growth.
4/1/11 Arrayit Corporation Announces the Product Launch of OvaDx®, the Market's First Pre-Symptomatic Screening Test for Ovarian Cancer.
9/20/10 Arrayit Corporation Completes Proteomics Platform Installation and Training at the National Institutes of Health.
8/23/10 Arrayit Corporation Announces Premarket Approval (PMA) Submission Strategy for OvaDx®.

Learn, Explore and Discover

More News
8/15/10 Arrayit Corporation Adds 128 New Products to Its Life Sciences Tools Portfolio.
6/16/10 Arrayit Corporation Technology May Provide Vital Clues to Detoxification of the Oceans.
5/10/10 Arrayit Corporation Reports Strong Surge in Customer Demand for the Company's Leading Edge Life Sciences Microarray Instruments.
4/20/10 Arrayit Corporation to Present at Southern California Investment Association Summer Capital Conference.
4/15/10 Arrayit Achieves Significant Progress in First Quarter 2010.
2/4/10 Arrayit Wins Landmark DNA Testing Patent in Israel.
1/25/10 Arrayit Corporation's Proteomic Biomarkers Clear the Way for Pre-Symptomatic Detection of Ovarian Cancer and Other Major Diseases.